IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasis

Conclusions These results collectively demonstrate IMB5036 can be a promising therapeutic candidate for patients with HCC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research